[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[C:5]([N+:9]([O-])=O)=[CH:4][C:3]=1[CH2:12][N:13]1[C:17](=[O:18])[C:16]([CH3:20])([CH3:19])[CH2:15][O:14]1>C(O)C.[Pt]=O>[Cl:1][C:2]1[CH:7]=[C:6]([F:8])[C:5]([NH2:9])=[CH:4][C:3]=1[CH2:12][N:13]1[C:17](=[O:18])[C:16]([CH3:20])([CH3:19])[CH2:15][O:14]1By the method of Example 3, Step C, 16.0 g (0.052 mole) of 2-[(2-chloro-4-fluoro-5-nitrophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone was hydrogenated in the presence of 0.2 g of platinum oxide in 250 ml of ethanol, yielding 2-[(2-chloro-4-fluoro-5-aminophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone.